Healthcare provider profile · identity verified

Drew A Kepple, MD

Internal Medicine · AVON, IN · NPI 1104117167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	589	167
Amlodipine Besylate	Amlodipine Besylate	354	98
Lisinopril	Lisinopril	343	95
Levothyroxine Sodium	Levothyroxine Sodium	298	72
Losartan Potassium	Losartan Potassium	231	62
Omeprazole	Omeprazole	223	55
Gabapentin	Gabapentin	170	38
Hydrochlorothiazide	Hydrochlorothiazide	162	41
Metformin Hcl	Metformin Hcl	158	44
Trazodone Hcl	Trazodone Hcl	139	41
Rosuvastatin Calcium	Rosuvastatin Calcium	132	42
Metformin Hcl Er	Metformin Hcl	127	36
Bupropion Xl	Bupropion Hcl	121	27
Pantoprazole Sodium	Pantoprazole Sodium	118	28
Escitalopram Oxalate	Escitalopram Oxalate	117	33
Metoprolol Succinate	Metoprolol Succinate	109	27
Duloxetine Hcl	Duloxetine Hcl	108	21
Tamsulosin Hcl	Tamsulosin Hcl	104	31
Jardiance	Empagliflozin	102	21
Ozempic	Semaglutide	94	16
Montelukast Sodium	Montelukast Sodium	92	27
Albuterol Sulfate Hfa	Albuterol Sulfate	88	37
Potassium Chloride	Potassium Chloride	84	23
Simvastatin	Simvastatin	83	21
Pregabalin	Pregabalin	80	23
Alendronate Sodium	Alendronate Sodium	78	24
Sertraline Hcl	Sertraline Hcl	74	22
Mounjaro	Tirzepatide	61	11
Pravastatin Sodium	Pravastatin Sodium	61	15
Chlorthalidone	Chlorthalidone	59	14
Allopurinol	Allopurinol	56	12
Carvedilol	Carvedilol	51	15
Fluticasone Propionate	Fluticasone Propionate	48	25
Metoprolol Tartrate	Metoprolol Tartrate	46	14
Furosemide	Furosemide	43	21
Trulicity	Dulaglutide	43	12
Buspirone Hcl	Buspirone Hcl	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	suppressed
Ezetimibe	Ezetimibe	40	14
Amitriptyline Hcl	Amitriptyline Hcl	39	suppressed
Mirtazapine	Mirtazapine	39	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	12
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	21
Valsartan	Valsartan	32	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Glipizide	Glipizide	31	suppressed
Eliquis	Apixaban	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Januvia	Sitagliptin Phosphate	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	13
Farxiga	Dapagliflozin Propanediol	26	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Prednisone	Prednisone	25	17
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Colchicine	Colchicine	24	suppressed
Nystatin	Nystatin	24	suppressed
Naltrexone Hcl	Naltrexone Hcl	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Atenolol	Atenolol	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Naproxen	Naproxen	21	suppressed
Torsemide	Torsemide	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Carisoprodol	Carisoprodol	19	suppressed
Finasteride	Finasteride	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Famotidine	Famotidine	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Tramadol Hcl	Tramadol Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Synthroid	Levothyroxine Sodium	17	suppressed
Linzess	Linaclotide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Cephalexin	Cephalexin	15	13
Fluticasone-Salmeterol Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Ramipril	Ramipril	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error